TransMedics Group, Inc. Common Stock (TMDX) Stock Price

TMDXStock

$88.43−24.24%52W

Market Cap$3.07B

P/E16.29x

PEG Ratio1.24

Div yield—

Beta1.98

TMDX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-47.75%

Price vs S&P 500 (4W)6.89%

PEG Ratio1.24

VGM Score53.93

P/E Ratio (Annual)16.29x

P/CF (Annual)16.08x

Book Value / Share (Quarterly)$14.96

P/TBV (Annual)8.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)86.42%

Cash Flow / Share (Quarterly)$2.28

Price vs S&P 500 (YTD)-40.13%

Gross Margin (TTM)58.69%

Net Profit Margin (TTM)22.69%

EPS (TTM)$3.73

10-Day Avg Trading Volume0.59M

EPS Excl Extra (TTM)$3.73

Revenue Growth (5Y)88.21%

EPS (Annual)$4.69

ROI (Annual)19.31%

Gross Margin (Annual)59.92%

Net Profit Margin (5Y Avg)-31.16%

Cash / Share (Quarterly)$13.65

P/E Basic Excl Extra (TTM)20.44x

Revenue Growth QoQ (YoY)20.70%

P/E Normalized (Annual)16.29x

ROA (Last FY)17.81%

Revenue Growth TTM (YoY)25.82%

EBITD / Share (TTM)$2.37

ROE (5Y Avg)-9.39%

Operating Margin (TTM)12.21%

Cash Flow / Share (Annual)$3.90

P/B Ratio5.98x

P/B Ratio (Quarterly)4.43x

Net Income / Employee (Annual)$211,900

EV / Revenue (TTM)5.22x

Net Interest Coverage (TTM)78.80x

ROA (TTM)12.35%

EPS Growth QoQ (YoY)-58.09%

EV / EBITDA (TTM)37.18x

EPS Incl Extra (Annual)$4.69

Current Ratio (Annual)7.14x

Quick Ratio (Quarterly)5.87x

3-Month Avg Trading Volume1.20M

52-Week Price Return-24.24%

EV / Free Cash Flow (Annual)26.12x

P/E Incl Extra (TTM)20.44x

Revenue / Employee (TTM)$744,400

Tangible BV / Share (Quarterly)$14.96

P/S Ratio (Annual)5.12x

Asset Turnover (Annual)0.57x

52-Week High$156.00

Operating Margin (5Y Avg)-29.75%

EPS Excl Extra (Annual)$4.69

CapEx CAGR (5Y)164.23%

Tangible BV CAGR (5Y)60.13%

26-Week Price Return-35.82%

Quick Ratio (Annual)6.41x

13-Week Price Return30.37%

Total Debt / Equity (Annual)1.08x

Current Ratio (Quarterly)6.63x

Enterprise Value$3.49B

Revenue / Share Growth (5Y)70.45%

Asset Turnover (TTM)0.54x

Book Value / Share Growth (5Y)29.30%

Revenue / Employee (Annual)$674,300

Inventory Turnover (Annual)5.09x

Pretax Margin (Annual)17.76%

Cash / Share (Annual)$14.25

3-Month Return Std Dev51.95%

Gross Margin (5Y Avg)64.56%

Net Income / Employee (TTM)$168,900

ROE (Last FY)40.22%

Net Interest Coverage (Annual)9.81x

EPS Basic Excl Extra (Annual)$4.69

P/FCF (TTM)34.01x

Receivables Turnover (TTM)6.40x

EV / Free Cash Flow (TTM)44.14x

Total Debt / Equity (Quarterly)1.66x

EPS Incl Extra (TTM)$3.73

Receivables Turnover (Annual)6.65x

ROI (TTM)13.24%

P/S Ratio (TTM)4.64x

Pretax Margin (5Y Avg)-33.98%

Revenue / Share (Annual)$14.94

Tangible BV / Share (Annual)$13.75

Forward P/E29.65x

Price vs S&P 500 (52W)-42.80%

P/E Ratio (TTM)20.44x

EPS Growth TTM (YoY)105.49%

Year-to-Date Return-27.31%

5-Day Price Return-5.52%

EPS Normalized (Annual)$4.69

ROA (5Y Avg)-5.43%

Net Profit Margin (Annual)31.43%

Month-to-Date Return15.58%

Cash Flow / Share (TTM)$-0.92

EBITD / Share (Annual)$2.68

Operating Margin (Annual)17.93%

LT Debt / Equity (Annual)1.06x

P/CF (TTM)21.24x

ROI (5Y Avg)-7.48%

P/E Excl Extra (TTM)20.44x

LT Debt / Equity (Quarterly)0.95x

EPS Basic Excl Extra (TTM)$3.73

P/TBV (Quarterly)4.43x

P/B Ratio (Annual)8.79x

Inventory Turnover (TTM)5.70x

Pretax Margin (TTM)10.85%

Book Value / Share (Annual)$13.81

Price vs S&P 500 (13W)28.42%

Beta1.98x

P/FCF (Annual)23.21x

Revenue / Share (TTM)$16.42

ROE (TTM)32.97%

52-Week Low$60.10

vGradeC

gGradeB

mGradeC

vgmGradeC

TMDX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	$0.48	$0.44	-7.44%(-$0.04)
Q1 2026	May 5, 2026	$0.61	$0.30	-50.92%(-$0.31)
Q4 2025	Feb 24, 2026	$0.37	$0.53	+40.95%(+$0.15)
Q3 2025	Oct 29, 2025	$0.36	$0.66	+83.33%(+$0.30)
Q2 2025	Jul 30, 2025	$0.43	$0.92	+114.79%(+$0.49)

TMDX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.15

4.00

3.95

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
TMDXTransMedics Group, Inc. Common Stock	C	B	C	$88.43
MDTMedtronic plc	B	C	C	$91.23
LIVNLivaNova PLC Ordinary Shares	C	B	B	$80.32
ITGRInteger Holdings Corporation	C	C	B	$125.33
AXGNAxogen, Inc. Common Stock	F	B	A	$51.47
BLFSBioLife Solutions Inc.	D	C	B	$36.38
CNMDCONMED Corporation	B	C	B	$49.98
CBLLCeriBell, Inc. Common Stock	D	A	B	$23.73
INMDInMode Ltd. Ordinary Shares	A	D	C	$14.85
CVCapsoVision, Inc. Common Stock	F	D	B	$5.93
ELMDElectromed, Inc.	D	B	C	$29.60
FOCLEDAP TMS S.A. American Depositary Shares	C	C	A	$4.31
STEXStreamex Corp. Common Stock	—	C	D	$0.77
STXSStereotaxis, Inc. Common Stock	D	D	D	$1.45
VANIVivani Medical, Inc. Common Stock (DE)	—	—	B	$1.42
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	$0.83
ECORelectroCore, Inc. Common Stock	C	A	B	$9.63
NRXSNeuraxis, Inc.	F	B	B	$6.00
OMOutset Medical, Inc. Common Stock	A	C	D	$3.94
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	$4.40
QTIQT Imaging Holdings, Inc. Common Stock	D	A	F	$3.09
IRIXIridex Corp	B	D	D	$0.71
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	$0.32
NDRAENDRA Life Sciences Inc. Common Stock	D	—	B	$5.00
NXLNexalin Technology, Inc. Common Stock	D	C	F	$0.25
NUWENuwellis, Inc. Common Stock	A	D	F	$0.89
EDAPEDAP TMS SA	C	B	B	$4.34
EYESCorgi Data & Surveillance ETF	—	C	B	$30.10
FONRFonar Corporation	B	D	B	$0.00
MASIMasimo Corporation	D	D	C	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	$0.12

About TransMedics Group, Inc. Common Stock

TransMedics Group Inc develops the Organ Care System (OCS), a portable organ perfusion and monitoring platform that preserves donor organs in near-physiologic conditions outside the body. The company's technology addresses significant limitations of traditional cold storage preservation, potentially improving organ quality and transplant outcomes. As a commercial-stage medical technology company, TransMedics is expanding its organ preservation system across multiple transplant disease states.